Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B

被引:512
作者
van Montfort, RLM [1 ]
Congreve, M [1 ]
Tisi, D [1 ]
Carr, R [1 ]
Jhoti, H [1 ]
机构
[1] Astex Technol Ltd, Cambridge CB4 0QA, England
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nature01681
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Protein tyrosine phosphatases regulate signal transduction pathways involving tyrosine phosphorylation(1) and have been implicated in the development of cancer, diabetes, rheumatoid arthritis and hypertension(2). Increasing evidence suggests that the cellular redox state is involved in regulating tyrosine phosphatase activity through the reversible oxidization of the catalytic cysteine to sulphenic acid (Cys-SOH)(3-6). But how further oxidation to the irreversible sulphinic (Cys-SO2H) and sulphonic (Cys-SO3H) forms is prevented remains unclear. Here we report the crystal structures of the regulatory sulphenic and irreversible sulphinic and sulphonic acids of protein tyrosine phosphatase 1B (PTP1B), an important enzyme in the negative regulation of the insulin receptor(7,8) and a therapeutic target in type II diabetes and obesity(9). We also identify a sulphenyl-amide species that is formed through oxidation of its catalytic cysteine. Formation of the sulphenyl-amide causes large changes in the PTP1B active site, which are reversible by reduction with the cellular reducing agent glutathione. The sulphenyl-amide is a protective intermediate in the oxidative inhibition of PTP1B. In addition, it may facilitate reactivation of PTP1B by biological thiols and signal a unique state of the protein.
引用
收藏
页码:773 / 777
页数:5
相关论文
共 23 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   Protein phosphatases [J].
Barford, D .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1995, 5 (06) :728-734
[3]   PURIFICATION AND CRYSTALLIZATION OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN-TYROSINE-PHOSPHATASE 1B EXPRESSED IN ESCHERICHIA-COLI [J].
BARFORD, D ;
KELLER, JC ;
FLINT, AJ ;
TONKS, NK .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 239 (05) :726-730
[4]   CRYSTAL-STRUCTURE OF HUMAN PROTEIN-TYROSINE-PHOSPHATASE 1B [J].
BARFORD, D ;
FLINT, AJ ;
TONKS, NK .
SCIENCE, 1994, 263 (5152) :1397-1404
[5]   Protein-sulfenic acids: Diverse roles for an unlikely player in enzyme catalysis and redox regulation [J].
Claiborne, A ;
Yeh, JI ;
Mallett, TC ;
Luba, J ;
Crane, EJ ;
Charrier, V ;
Parsonage, D .
BIOCHEMISTRY, 1999, 38 (47) :15407-15416
[6]   PROTEIN-SULFENIC ACID STABILIZATION AND FUNCTION IN ENZYME CATALYSIS AND GENE-REGULATION [J].
CLAIBORNE, A ;
MILLER, H ;
PARSONAGE, D ;
ROSS, RP .
FASEB JOURNAL, 1993, 7 (15) :1483-1490
[7]   Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: Evidence for a sulfenic acid intermediate and implications for redox regulation [J].
Denu, JM ;
Tanner, KG .
BIOCHEMISTRY, 1998, 37 (16) :5633-5642
[8]   Protein tyrosine phosphatases: mechanisms of catalysis and regulation [J].
Denu, JM ;
Dixon, JE .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (05) :633-641
[9]   Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene [J].
Elchebly, M ;
Payette, P ;
Michaliszyn, E ;
Cromlish, W ;
Collins, S ;
Loy, AL ;
Normandin, D ;
Cheng, A ;
Himms-Hagen, J ;
Chan, CC ;
Ramachandran, C ;
Gresser, MJ ;
Tremblay, ML ;
Kennedy, BP .
SCIENCE, 1999, 283 (5407) :1544-1548
[10]  
Goldstein Barry J., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P265, DOI 10.2174/1568008013341163